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ABSTRACT
We report the case of a 65-year-old male who presented 
with a 1-week history of right periorbital pain and 
progressive visual loss. He had a history of ulcerative 
colitis and was taking oral corticosteroids and mesala-
zine. Neurological and radiological examination demon-
strated a rare case of invasive fungal rhinosinusitis that 
began with orbital apex syndrome. Initial endoscopic 
sinus surgery was performed and fungal culture identi-
fied Aspergillus fumigatus. Although antifungal treat-
ment was started empirically before the operation, the 
patient had improved orbital pain but continued to have 
decreased right vision. Five months after the first surgi-
cal procedure, his condition deteriorated, including loss 
of consciousness, and a right temporal lobe abscess was 
found and surgically drained. Since then, the patient 
received antifungal treatment for 4 years without recur-
rence. Invasive fungal rhinosinusitis with orbital apex 
syndrome should be treated with long-term postopera-
tive antifungal medication. It should be noted that even 
in immunosuppressive individuals such as ulcerative 
colitis, fungal rhinosinusitis with orbital apex syndrome 
may become severe.
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Glucocorticoid administration is a well-established 
treatment strategy for patients with ulcerative colitis. 
Patients who cannot be weaned off glucocorticoids may 
require an additional immunomodulatory medication, 
such as azathioprine. However, an important concern 
associated with systemic glucocorticoid therapy is the 
dose-dependent increase in the risk of developing infec-
tious diseases, especially those involving common bac-
terial, viral, parasitic and fungal species.1 When used 
in combination with other immunosuppressive drugs, 
glucocorticoids may result in opportunistic infections 
by low-pathogenicity organisms; these conditions may 
either be newly acquired or due to reactivation of latent 
infections.2 Immunosuppressive therapy is the main 
risk factor for opportunistic infections in patients with 
inflammatory bowel disease (IBD).3 The risk of fungal 
infection appears to be low in IBD, but the morbidity 
and mortality are high.3
Orbital apex syndrome (OAS) is a syndrome that 
presents as ophthalmoplegia, proptosis, ptosis and vision 
decline.4 In immunocompromised individuals, fungal 
rhinosinusitis can cause OAS, with Aspergillus being 
the most common pathogen.5 Fungal rhinosinusitis is 
broadly divided into invasive forms and non-invasive 
forms, and invasive forms are rare. Opportunistic infec-
tions frequently involve the orbit and sinuses, with pos-
sible secondary intracranial extension. The prognosis of 
central nervous system (CNS) aspergillosis, especially 
intracerebral aspergillosis, is very poor, with high mor-
tality ranging from 66% to 100%.6
To the best of our knowledge, CNS aspergillosis 
has not been previously reported in patients with IBD. 
Here we describe a patient with ulcerative colitis receiv-
ing a combination of systemic glucocorticoids and me-
salazine, who developed a temporal brain abscess after 
intervention with invasive fungal rhinosinusitis. The 
patient has survived for more than 4 years following 
right temporal lobectomy and voriconazole maintenance 
therapy, although he experienced residual monocular 
blindness. In addition to the case presentation, we 
discuss the background and mechanism of brain abscess 
caused by invasive fungal rhinosinusitis.
PATIENT REPORT
A 65-year-old Japanese male presented with a 1-month 
history of blurred vision. He also complained of right 
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periorbital pain and progressive visual loss in the last 
week. He had no previous ophthalmic history. He had 
a 6-month history of ulcerative colitis (S1 Montreal 
classification). He was receiving prednisone 25 mg/day 
and mesalazine 4800 mg/day. Neurological examination 
revealed complete right-sided ophthalmoplegia with 
mydriasis, first trigeminal division hypoalgesia, dimin-
ished corneal reflex and counting fingers acuity in right 
eye. Magnetic resonance imaging showed an enhancing 
lesion on the right posterior ethmoid sinus extending to 
the orbital apex (Fig. 1). Blood tests showed only mild 
inflammation and a cerebrospinal fluid test showed 
no particular abnormalities. Biochemical examination 
revealed that the serum aspergillus galactomannan anti-
gen, β-D-glucan, and aspergillus-specific antibody IgG 
levels were 0.2 (normal range < 0.5), 2.3 pg/mL (normal 
range < 11.0 pg/mL), and 0.1 AU/mL (negative range < 
0.34), respectively. Given the examination results, OAS 
was considered. The presumptive diagnosis was either 
a skull base tumor or sinusitis that extended into the 
orbit and became an abscess. Cefazolin (3 g/day) and 
voriconazole (400 mg/day) were given by intravenous 
infusion. After a week of conservative treatment, a 
computed tomography scan showed that the lesion was 
still present, and therefore endoscopic sinus surgery 
(ESS) was performed via opening of the orbital apex.
A fungal mass was discovered in the posterior 
ethmoid sinus, and an abscess was found at the apex of 
the orbit when the bone defect site was opened. Mucosal 
tissue revealed invasive, branching, septate fungal 
hyphae with minimal inflammation histologically (Fig. 
2). Fungal culture identified Aspergillus fumigatus 
infection. Postoperative treatment included continued 
voriconazole administration as well as sinus irrigation 
and dilatation. The patient’s trigeminal pain resolved, 
but he had light perception in his right eye after a 
month. For treatment of ulcerative colitis, prednisolone 
was gradually reduced to 5 mg/day and mesalazine was 
maintained at 4800 mg/day. The patient was discharged 
after voriconazole was switched from intravenous to 
oral administration.
Five months after the first surgical procedure, the 
patient presented with episodes of right orbital pain and 
loss of consciousness. He was urgently hospitalized and 
imaging tests revealed a right temporal abscess (Fig. 3). 
He had his right eye blind. Chest X-ray was normal. In 
addition, the serum aspergillus galactomannan antigen 
and β-D-glucan levels were normal. He was still taking 
voriconazole, but therapeutic drug monitoring (TDM) 
for voriconazole had not been carried out for 3 months 
and the blood level of voriconazole had dropped to 
0.4 μg/mL. Despite puncture drainage and 3 weeks of 
antifungal treatment, a computed tomography scan still 
showed a residual abscess, and therefore complete right 
temporal lobectomy was performed with simultaneous 
ESS. Histological examination of the sinuses and the 
bottom of the middle cranial fossa revealed an intra-
cranial abscess and granuloma, leading to a diagnosis 
of aspergillosis. The dura was reconstructed with tem-
poralis fascia and the dead space in the skull was filled 
with abdominal fat. The patient was discharged 1 month 
later. He has survived for more than 4 years thereafter 
with maintenance of voriconazole using TDM.
Fig. 1. Preoperative gadolinium-enhanced T1-weighted axial im-
age. Arrowheads show an enhanced lesion on the right posterior 
ethmoid sinus extending to the orbital apes.
Fig. 2. Photomicrography of the surgical specimen showing some 
hyphae of Aspergillus fumigatus in the orbital tissues (hematoxylin 
and eosin stain). Bar = 20 μm.
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DISCUSSION
Glucocorticoids and mesalazine are essential first-line 
treatments for ulcerative colitis and are often used in 
patients with mild or moderate disease.2 Corticosteroids 
predispose patients to infections, especially when used 
at high doses and/or for long periods of time, or in com-
bination with other immunosuppressive regimens.1 Our 
patient was unable to discontinue prednisolone, but its 
dose was quickly reduced. However, he was taking long-
term mesalazine, a multi-matrix-type anti-inflammatory 
drug. Known adverse effects of mesalazine include 
blood dyscrasias such as leucopenia and thrombocy-
topenia.7 Mesalazine has been reported to eliminate 
active enzymes released from inflammatory cells such 
as neutrophils and macrophage.8 These effects on the 
blood may lead to an immunocompromised state and 
therefore to uncommon infections such as brain abscess 
due to Aspergillus. Further, it has been reported that 
long-term administration of mesalazine was associated 
with abscess caused by central skull-base osteomyeli-
tis.9 Although our patient’s blood count did not reveal 
any overt abnormalities, long-term mesalazine may 
have altered his immune system, rendering it vulnerable 
to brain abscess. We emphasize that this is a single case 
study and causation could not be proved.
The main routes of fungal CNS contamination are 
hematogenous dissemination from a distant primary 
source, mainly the lungs, and contiguous spread from an 
adjacent focus such as the orbit or paranasal sinuses.10 
Once a fungus invades the paranasal sinus mucosa, it 
spreads to adjacent structures by invading bone, nerve 
and blood vessels.11 Involvement of the CNS is present 
in 10―15% of patients with disseminated disease,12 and 
it may result in various pathological conditions such 
as a single solid granuloma, abscess or necrotic lesion. 
One case report described invasive fungal aspergillosis 
with OAS that developed and later transformed into a 
temporal brain abscess after steroid administration.10 
Because fungi can invade the cavernous sinus via the 
orbital apex, OAS is considered to be an important sign 
heralding CNS involvement.5 In our case, while there 
were no lung lesions, magnetic resonance imaging 
revealed that the lateral wall of the sphenoid sinus had 
disappeared (Fig. 3); that site may have been close to the 
first abscess. Reactivation of aspergillosis at the apex of 
the orbit may have extended to the outside of the sphe-
noid sinus via the optic canal, leading to a brain abscess.
In combination with systemic antifungal chemo-
therapy, radical removal of cerebral aspergilloma can 
be curative in Aspergillus brain abscess, and lobectomy 
is an acceptable surgical option when noneloquent 
areas of the brain are involved in patients with a single 
Aspergillus fumigatus abscess.13 In our case, the lesion 
was on the right side, so it was judged that it could be 
resected with few complications. In addition, voricon-
azole is the first-line antifungal drug,14 and treatment 
for more than half a year has been recommended for 
invasive fungal rhinosinusitis associated with OAS.15 In 
our patient with severe disease, voriconazole has been 
administered for 4 years using TDM.
In conclusion, patients with invasive fungal rhi-
nosinusitis and OAS should be treated postoperatively 
with a long-term regimen of antifungal medication. In 
such cases, attention should be paid to the possibility of 
developing a brain abscess, especially in immunosup-
pressed individuals. Opportunistic infections with 
low-pathogenicity organisms or reactivation of latent 
infections should always be kept in mind as differential 
Fig. 3. Gadolinium-enhanced T1-weighted axial (A) and coronal (B) image depicting a right temporal abscess (arrowheads) five months 
after the first surgical procedure. An enhanced lesion centered on the right optic canal also extends to the lower part of the cavernous 
sinus (arrow).
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diagnoses in patients with ulcerative colitis who are 
taking glucocorticoids and mesalazine. This case 
emphasizes that proper surgical drainage and long-term 
antifungal administration are very effective in control-
ling infection by invasive fungal rhinosinusitis.
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